Please sign in to follow a disease.
Vulvovaginal candidiasis
MONDO:0006014Infection of the vulva and vagina with a fungus of the genus CANDIDA. It is a disease associated with HIV infection.
Also known as: candidal vulvovaginitis, candidal: [vulvovaginitis NOS] or [cervix], candidal: cervix, candidiasis of vulva and vagina, monilial vulvovaginitis, vaginal candidiasis, vulvovaginal candidiasis
27 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Friendly bacteria vs. yeast: can a probiotic stop infections from coming back?
Disease control CompletedThis trial tests whether taking a specific probiotic supplement (Lactobacillus crispatus Lc-G22) alongside standard antifungal treatment can help prevent repeat vaginal yeast infections. One hundred women with a history of frequent yeast infections will receive either the probiot…
Phase: NA • Sponsor: BioGrowing Co., Ltd • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Could a daily postbiotic help fight yeast infections?
Disease control CompletedThis trial investigates whether taking a postbiotic supplement daily for four weeks can help ease symptoms of vaginal yeast infections in women. Participants are sexually active women with a confirmed yeast infection. The study compares the postbiotic to a placebo to see if it im…
Phase: PHASE2, PHASE3 • Sponsor: Min-Tze LIONG • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New yeast infection pill could stop repeat episodes
Disease control CompletedThis study tested a new oral medication, oteseconazole, to see if it can prevent recurrent yeast infections in women who have had at least three infections in the past year. Over 400 participants took either the study drug or a placebo for 12 weeks after an initial treatment, and…
Phase: PHASE3 • Sponsor: Mycovia Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New pill may keep yeast infections away for good
Disease control CompletedThis study tested a new oral medication, oteseconazole, to see if it can prevent recurrent yeast infections in women who have had at least three infections in the past year. Participants first received standard treatment for their current infection, then took either oteseconazole…
Phase: PHASE3 • Sponsor: Mycovia Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Shining a light on vaginal infections: new device tested
Disease control CompletedThis study tested a device that uses UVA and blue light to treat bacterial vaginosis and yeast infections. 38 women received one or two light treatments. Researchers checked if symptoms improved and if the vaginal microbiome became healthier. The goal is to find an alternative to…
Phase: NA • Sponsor: UVISA Health ApS • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
One shot wonder? new antibiotic trial for Kids' skin infections
Disease control CompletedThis study tested a single dose of the antibiotic oritavancin in 118 children aged 3 months to 12 years with acute bacterial skin infections. The goal was to see if it is safe and tolerable. Researchers also looked at how the drug works in the body and whether it cures the infect…
Phase: PHASE2 • Sponsor: Melinta Therapeutics, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New vaginal device shows promise for yeast infections in small trial
Disease control CompletedThis study tested a vaginal pessary (Gedea) in 26 women with yeast infections. Participants used the device daily for 6 days. Researchers checked if symptoms like itching and burning went away by day 7 to 14. The goal was to see if the device could safely treat the infection with…
Phase: NA • Sponsor: Gedea Biotech AB • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Quick vaginal infection test could beat standard diagnosis
Diagnosis CompletedThis study tested whether a rapid point-of-care test (Xpert® Xpress MVP) helps doctors diagnose vaginal infections more accurately than usual methods. 351 women with symptoms like discharge or itching were randomly assigned to either usual care or the rapid test. Researchers then…
Phase: NA • Sponsor: Sharon L Hillier • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
Study links vaginal germs to preterm birth risk
Knowledge-focused CompletedThis study followed 603 pregnant women in South Africa to see if infections or bacteria in the vagina are linked to how early they give birth. Researchers tested for sexually transmitted infections, yeast, and other germs at the start of pregnancy and again at 30-34 weeks. The go…
Sponsor: University of Bern • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:35 UTC